Commit To Purchase Five Prime Therapeutics At $40, Earn 22.8% Annualized Using Options
May 03, 2016 at 11:44 AM EDT
Investors eyeing a purchase of Five Prime Therapeutics, Inc (FPRX) shares, but cautious about paying the going market price of $46.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $40 strike, which has a bid at the time of this writing of $3.40..